Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 10, 2024

SELL
$209.01 - $232.56 $985,482 - $1.1 Million
-4,715 Reduced 78.89%
1,262 $276,000
Q4 2023

Feb 07, 2024

SELL
$197.69 - $227.29 $130,673 - $150,238
-661 Reduced 9.96%
5,977 $1.36 Million
Q3 2023

Nov 08, 2023

BUY
$201.05 - $221.7 $110,778 - $122,156
551 Added 9.05%
6,638 $1.34 Million
Q2 2023

Aug 09, 2023

BUY
$211.93 - $241.33 $678,176 - $772,256
3,200 Added 110.84%
6,087 $1.47 Million
Q1 2023

Apr 20, 2023

SELL
$213.32 - $257.83 $1.87 Million - $2.26 Million
-8,778 Reduced 75.25%
2,887 $663,000
Q4 2022

Feb 10, 2023

BUY
$203.72 - $248.97 $1.59 Million - $1.94 Million
7,785 Added 200.64%
11,665 $2.75 Million
Q3 2022

Oct 17, 2022

SELL
$204.81 - $262.19 $62,262 - $79,705
-304 Reduced 7.27%
3,880 $794,000
Q2 2022

Aug 02, 2022

BUY
$213.86 - $277.87 $127,674 - $165,888
597 Added 16.64%
4,184 $980,000
Q1 2022

May 09, 2022

SELL
$259.82 - $298.18 $318,539 - $365,568
-1,226 Reduced 25.47%
3,587 $946,000
Q4 2021

Feb 14, 2022

SELL
$271.6 - $314.21 $54,863 - $63,470
-202 Reduced 4.03%
4,813 $1.51 Million
Q3 2021

Oct 29, 2021

SELL
$274.82 - $308.34 $14,290 - $16,033
-52 Reduced 1.03%
5,015 $1.41 Million
Q2 2021

Aug 11, 2021

BUY
$251.87 - $278.14 $128,705 - $142,129
511 Added 11.22%
5,067 $1.4 Million
Q1 2021

May 11, 2021

BUY
$204.88 - $255.03 $481,672 - $599,575
2,351 Added 106.62%
4,556 $1.16 Million
Q3 2020

Oct 30, 2020

BUY
$167.03 - $201.3 $83,515 - $100,650
500 Added 29.33%
2,205 $415,000
Q2 2020

Jul 22, 2020

SELL
$113.31 - $182.44 $215,289 - $346,636
-1,900 Reduced 52.7%
1,705 $284,000
Q1 2020

May 14, 2020

SELL
$104.32 - $195.28 $104,320 - $195,280
-1,000 Reduced 21.72%
3,605 $456,000
Q4 2019

Feb 10, 2020

BUY
$163.48 - $173.61 $752,825 - $799,474
4,605 New
4,605 $779,000

Others Institutions Holding LH

About LABORATORY CORP OF AMERICA HOLDINGS


  • Ticker LH
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 89,600,000
  • Market Cap $20.7B
  • Description
  • Laboratory Corporation of America Holdings operates as a global life sciences company that provides vital information to help doctors, hospitals, pharmaceutical companies, researchers, and patients make clear and confident decisions. It operates in two segments, Labcorp Diagnostics (Dx) and Labcorp Drug Development (DD). It offers various tests,...
More about LH
Track This Portfolio

Track Banque Cantonale Vaudoise Portfolio

Follow Banque Cantonale Vaudoise and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Banque Cantonale Vaudoise, based on Form 13F filings with the SEC.

News

Stay updated on Banque Cantonale Vaudoise with notifications on news.